These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 11404191
1. Immunoreactivity to monoclonal antibody, Hep Par 1, in human hepatocellular carcinomas according to histopathological grade and histological pattern. Kumagai I, Masuda T, Sato S, Ishikawa K. Hepatol Res; 2001 Jul; 20(3):312-319. PubMed ID: 11404191 [Abstract] [Full Text] [Related]
2. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors. Amarapurkar AD, Rege JD, Joshi AS, Vaiphei K, Amarapurkar DN. Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880 [Abstract] [Full Text] [Related]
3. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Chu PG, Ishizawa S, Wu E, Weiss LM. Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084 [Abstract] [Full Text] [Related]
4. Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody Hepatocyte Paraffin 1. Sugiki T, Yamamoto M, Aruga A, Takasaki K, Nakano M. J Surg Oncol; 2004 Nov 01; 88(2):104-7. PubMed ID: 15499598 [Abstract] [Full Text] [Related]
5. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study. Villari D, Caruso R, Grosso M, Vitarelli E, Righi M, Barresi G. Pathology; 2002 Oct 01; 34(5):423-6. PubMed ID: 12408340 [Abstract] [Full Text] [Related]
6. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma. Kakar S, Muir T, Murphy LM, Lloyd RV, Burgart LJ. Am J Clin Pathol; 2003 Mar 01; 119(3):361-6. PubMed ID: 12645337 [Abstract] [Full Text] [Related]
7. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Fan Z, van de Rijn M, Montgomery K, Rouse RV. Mod Pathol; 2003 Feb 01; 16(2):137-44. PubMed ID: 12591966 [Abstract] [Full Text] [Related]
8. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma. Shiran MS, Isa MR, Sherina MS, Rampal L, Hairuszah I, Sabariah AR. Malays J Pathol; 2006 Dec 01; 28(2):87-92. PubMed ID: 18376797 [Abstract] [Full Text] [Related]
9. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma. Hanif R, Mansoor S. J Coll Physicians Surg Pak; 2014 Mar 01; 24(3):186-9. PubMed ID: 24613115 [Abstract] [Full Text] [Related]
10. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Leong AS, Sormunen RT, Tsui WM, Liew CT. Histopathology; 1998 Oct 01; 33(4):318-24. PubMed ID: 9822920 [Abstract] [Full Text] [Related]
11. Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma. Nguyen T, Phillips D, Jain D, Torbenson M, Wu TT, Yeh MM, Kakar S. Arch Pathol Lab Med; 2015 Aug 01; 139(8):1028-34. PubMed ID: 26230595 [Abstract] [Full Text] [Related]
12. Hepatocyte Paraffin 1 Immunoreactivity in Early Colon Carcinogenesis. Nemolato S, Ravarino A, Fanni D, Coni P, Di Felice E, Senes G, Faa G. Gastroenterology Res; 2009 Oct 01; 2(5):277-281. PubMed ID: 27956971 [Abstract] [Full Text] [Related]
13. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples. Lugli A, Tornillo L, Mirlacher M, Bundi M, Sauter G, Terracciano LM. Am J Clin Pathol; 2004 Nov 01; 122(5):721-7. PubMed ID: 15491968 [Abstract] [Full Text] [Related]
14. Histological grade of hepatocellular carcinoma predicted by quantitative diffusion-weighted imaging. Guo W, Zhao S, Yang Y, Shao G. Int J Clin Exp Med; 2015 Nov 01; 8(3):4164-9. PubMed ID: 26064326 [Abstract] [Full Text] [Related]
15. Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen. Fasano M, Theise ND, Nalesnik M, Goswami S, Garcia de Davila MT, Finegold MJ, Greco MA. Mod Pathol; 1998 Oct 01; 11(10):934-8. PubMed ID: 9796718 [Abstract] [Full Text] [Related]
16. Immunohistochemical characterization of canine hyperplastic hepatic lesions and hepatocellular and biliary neoplasms with monoclonal antibody hepatocyte paraffin 1 and a monoclonal antibody to cytokeratin 7. Ramos-Vara JA, Miller MA, Johnson GC. Vet Pathol; 2001 Nov 01; 38(6):636-43. PubMed ID: 11732796 [Abstract] [Full Text] [Related]
17. [The magnetic resonance and histological correlations in hepatocellular carcinoma]. Bartolozzi C, Lencioni R, Caramella D, Paolicchi A, Russo R, Romani R. Radiol Med; 1994 Nov 01; 87(1-2):90-5. PubMed ID: 8128039 [Abstract] [Full Text] [Related]
18. Immunohistochemical expression of manganese superoxide dismutase in hepatocellular carcinoma, using a specific monoclonal antibody. Aida Y, Maeyama S, Takakuwa T, Uchikoshi T, Endo Y, Suzuki K, Taniguchi N. J Gastroenterol; 1994 Aug 01; 29(4):443-9. PubMed ID: 7951854 [Abstract] [Full Text] [Related]
19. Immunohistochemical characterization of canine intestinal epithelial and mesenchymal tumours with a monoclonal antibody to hepatocyte paraffin 1 (Hep Par 1). Ramos-Vara JA, Miller MA. Histochem J; 2002 Aug 01; 34(8-9):397-401. PubMed ID: 12814187 [Abstract] [Full Text] [Related]
20. Immunoreactivity of hepatocyte paraffin 1 monoclonal antibody in cutaneous metastatic tumors. Kanitakis J, Chouvet B, Claudy A, Scoazec JY. Am J Clin Pathol; 2004 Jul 01; 122(1):85-9. PubMed ID: 15272534 [Abstract] [Full Text] [Related] Page: [Next] [New Search]